Use of Resmetirom in Patients With Metabolic Dysfunction-Associated Steatohepatitis.

Gastroenterol Hepatol (N Y)

Visiting Professor of Hepatology Radcliffe Department of Medicine, University of Oxford Chairman and Founder, Pinnacle Clinical Research Chairman and Co-Founder, Summit Clinical Research Founder and CEO, Apex Mobile Clinical Research.

Published: August 2024

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11346006	PMC

Publication Analysis

Top Keywords

resmetirom patients

patients metabolic

metabolic dysfunction-associated

dysfunction-associated steatohepatitis

resmetirom

metabolic

dysfunction-associated

steatohepatitis

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!